The Impact of Liquid Biopsy in Advanced Ovarian Cancer Care
An analysis of cfDNA and ctDNA offers a non-invasive clinical tool for monitoring the primary tumour to establish a complete cytoreduction and to diagnose recurrence early.
Authors
- Sarai Canete-Mota (ORCID: https://orcid.org/0000-0002-4401-8005)
- Anna Serra (ORCID: https://orcid.org/0000-0002-7535-057X)
- Anna Jaureguí (ORCID: https://orcid.org/0000-0003-1917-9939)
- Manuela Barneo‐Muñoz (ORCID: https://orcid.org/0000-0003-4662-2887)
- Juan Gilabert–Estellés (ORCID: https://orcid.org/0000-0002-3992-1929)
- Alexander Neef (ORCID: https://orcid.org/0000-0002-4170-9425)
- Antoni Llueca (ORCID: https://orcid.org/0000-0003-3723-8795)
- Maria Llueca
- Josep Marí‐Alexandre (ORCID: https://orcid.org/0000-0003-0625-4901)
- Sarai Tomás-Pérez (ORCID: https://orcid.org/0000-0003-0595-3129)
- Enrique Ochoa (ORCID: https://orcid.org/0000-0002-3502-2731)
- Blanca Segarra-Vidal (ORCID: https://orcid.org/0000-0003-3203-0725)
- María Teresa Climent (ORCID: https://orcid.org/0000-0001-5976-8792)
- M. Victoria Ibáñez (ORCID: https://orcid.org/0000-0001-7043-8233)
- Nuria Gutiérrez Ruiz
- Carla Bellido
Institutions
- Universitat Jaume I (ES)
- Hospital Universitari i Politècnic La Fe (ES)
- Hospital General Universitari de Castelló (ES)
- Hospital General Universitario De Valencia (ES)
- Fundación Hospital Provincial de Castellón (ES)
- Hospital Universitari Joan XXIII de Tarragona (ES)
Publication Details
- Journal
- Diagnostics
- Published
- 2024-08-26
- DOI
- https://doi.org/10.3390/diagnostics14171868
- Citations
- 8
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 2.28